Review of the role of the sentinel node biopsy in neoadjuvant chemotherapy in women with breast cancer and negative or positive axillary node at diagnosis
Authors:
- R. Ruano PérezRPR. Ruano Pérez
- A.C. Rebollo AguirreAAA.C. Rebollo Aguirre
- P. García-Talavera San MiguelPMP. García-Talavera San Miguel
- R. Díaz ExpósitoRER. Díaz Expósito
- S. Vidal-SicartSVS. Vidal-Sicart
- J.M. Cordero GarcíaJGJ.M. Cordero García
- D. Carrera SalazarDSD. Carrera Salazar
- M.E. Rioja MartínMMM.E. Rioja Martín
- 1 January 2018
- journal article
- review article
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
- Vol. 37 (1) , 63-70
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast CancerJAMA, 2013
- Imaging Response and Residual Metastatic Axillary Lymph Node Disease after Neoadjuvant Chemotherapy for Primary Breast CancerAnnals of Surgical Oncology, 2013
- Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studyThe Lancet Oncology, 2013
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialThe Lancet Oncology, 2010
- Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancerBritish Journal of Surgery, 2010
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer PatientsAnnals of Surgery, 2009
- Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric StudyJournal of Clinical Oncology, 2009
- La biopsia del ganglio centinela en cáncer de mama de más de 3 cm y axila clínicamente negativa frente a la indicación estándar T1-T2 < 3 cmRevista Española de Medicina Nuclear, 2008
- Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy Is Accurate in Breast Cancer Patients with a Clinically Negative Axillary Nodal Status at PresentationAnnals of Surgical Oncology, 2008
- Role of Sentinel Lymphadenectomy Combined with Intraoperative Ultrasound in the Assessment of Locally Advanced Breast Cancer After Neoadjuvant ChemotherapyAnnals of Surgical Oncology, 2006